<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://new.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Fri, 10 Jul 2026 17:15:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://new.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  S-8        MANGOCEUTICALS, INC.                 </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++MANGOCEUTICALS%2C+INC.+++++++++++++++++/26758037.html</link>
   <description>si-local-file:///var/storage/secattach/20260710/26758037.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++MANGOCEUTICALS%2C+INC.+++++++++++++++++/26758037.html</guid>
   <pubDate>Fri, 10 Jul 2026 17:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MGRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54870568</category>
   	  </item>
  <item>
   <title>Form  S-8        MANGOCEUTICALS, INC.                 </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++MANGOCEUTICALS%2C+INC.+++++++++++++++++/26758037.html</link>
   <description>si-local-file:///var/storage/secattach/20260710/26758037.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++MANGOCEUTICALS%2C+INC.+++++++++++++++++/26758037.html</guid>
   <pubDate>Fri, 10 Jul 2026 17:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MGRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54870568</category>
   	  </item>
  <item>
   <title>Form  8-K        MANGOCEUTICALS, INC.      For: Jun 29</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++MANGOCEUTICALS%2C+INC.++++++For%3A+Jun+29/26728429.html</link>
   <description>si-local-file:///var/storage/secattach/20260702/26728429.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++MANGOCEUTICALS%2C+INC.++++++For%3A+Jun+29/26728429.html</guid>
   <pubDate>Thu, 02 Jul 2026 16:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MGRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54870568</category>
   	  </item>
  <item>
   <title>Form  8-K        MANGOCEUTICALS, INC.      For: Jun 29</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++MANGOCEUTICALS%2C+INC.++++++For%3A+Jun+29/26728429.html</link>
   <description>si-local-file:///var/storage/secattach/20260702/26728429.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++MANGOCEUTICALS%2C+INC.++++++For%3A+Jun+29/26728429.html</guid>
   <pubDate>Thu, 02 Jul 2026 16:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MGRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54870568</category>
   	  </item>
  <item>
   <title>Form  10-Q       MANGOCEUTICALS, INC.      For: Mar 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++MANGOCEUTICALS%2C+INC.++++++For%3A+Mar+31/26521756.html</link>
   <description>si-local-file:///var/storage/secattach/20260519/26521756.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++MANGOCEUTICALS%2C+INC.++++++For%3A+Mar+31/26521756.html</guid>
   <pubDate>Tue, 19 May 2026 16:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MGRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54870568</category>
   	  </item>
  <item>
   <title>Form  10-Q       MANGOCEUTICALS, INC.      For: Mar 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++MANGOCEUTICALS%2C+INC.++++++For%3A+Mar+31/26521756.html</link>
   <description>si-local-file:///var/storage/secattach/20260519/26521756.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++MANGOCEUTICALS%2C+INC.++++++For%3A+Mar+31/26521756.html</guid>
   <pubDate>Tue, 19 May 2026 16:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MGRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54870568</category>
   	  </item>
  <item>
   <title>Form  NT 10-Q    MANGOCEUTICALS, INC.      For: Mar 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++MANGOCEUTICALS%2C+INC.++++++For%3A+Mar+31/26507107.html</link>
   <description>si-local-file:///var/storage/secattach/20260515/26507107.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++MANGOCEUTICALS%2C+INC.++++++For%3A+Mar+31/26507107.html</guid>
   <pubDate>Fri, 15 May 2026 16:45:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MGRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54870568</category>
   	  </item>
  <item>
   <title>Form  NT 10-Q    MANGOCEUTICALS, INC.      For: Mar 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++MANGOCEUTICALS%2C+INC.++++++For%3A+Mar+31/26507107.html</link>
   <description>si-local-file:///var/storage/secattach/20260515/26507107.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++MANGOCEUTICALS%2C+INC.++++++For%3A+Mar+31/26507107.html</guid>
   <pubDate>Fri, 15 May 2026 16:45:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MGRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54870568</category>
   	  </item>
  <item>
   <title>Form  10-K       MANGOCEUTICALS, INC.      For: Dec 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++MANGOCEUTICALS%2C+INC.++++++For%3A+Dec+31/26254418.html</link>
   <description>
&lt;p&gt;&lt;a target=&quot;_blank&quot; href=&quot;http://archive.fast-edgar.com/20260401/AP2ZV22CZC2R79TD222J2ZY2QDI8ZZ22ZL82&quot;&gt;http://archive.fast-edgar.com/20260401/AP2ZV22CZC2R79TD222J2ZY2QDI8ZZ22ZL82&lt;/a&gt;&lt;/p&gt;

&lt;p&gt;
Filed on: April 1, 2026
&lt;/p&gt;
</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++MANGOCEUTICALS%2C+INC.++++++For%3A+Dec+31/26254418.html</guid>
   <pubDate>Wed, 01 Apr 2026 06:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MGRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54870568</category>
   	  </item>
  <item>
   <title>Form  10-K       MANGOCEUTICALS, INC.      For: Dec 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++MANGOCEUTICALS%2C+INC.++++++For%3A+Dec+31/26254418.html</link>
   <description>
&lt;p&gt;&lt;a target=&quot;_blank&quot; href=&quot;http://archive.fast-edgar.com/20260401/AP2ZV22CZC2R79TD222J2ZY2QDI8ZZ22ZL82&quot;&gt;http://archive.fast-edgar.com/20260401/AP2ZV22CZC2R79TD222J2ZY2QDI8ZZ22ZL82&lt;/a&gt;&lt;/p&gt;

&lt;p&gt;
Filed on: April 1, 2026
&lt;/p&gt;
</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++MANGOCEUTICALS%2C+INC.++++++For%3A+Dec+31/26254418.html</guid>
   <pubDate>Wed, 01 Apr 2026 06:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MGRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54870568</category>
   	  </item>
  <item>
   <title>Form  NT 10-K    MANGOCEUTICALS, INC.      For: Dec 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++NT+10-K++++MANGOCEUTICALS%2C+INC.++++++For%3A+Dec+31/26252731.html</link>
   <description>si-local-file:///var/storage/secattach/20260331/26252731.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++NT+10-K++++MANGOCEUTICALS%2C+INC.++++++For%3A+Dec+31/26252731.html</guid>
   <pubDate>Tue, 31 Mar 2026 17:25:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MGRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54870568</category>
   	  </item>
  <item>
   <title>Form  NT 10-K    MANGOCEUTICALS, INC.      For: Dec 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++NT+10-K++++MANGOCEUTICALS%2C+INC.++++++For%3A+Dec+31/26252731.html</link>
   <description>si-local-file:///var/storage/secattach/20260331/26252731.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++NT+10-K++++MANGOCEUTICALS%2C+INC.++++++For%3A+Dec+31/26252731.html</guid>
   <pubDate>Tue, 31 Mar 2026 17:25:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MGRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54870568</category>
   	  </item>
  <item>
   <title>Form  4          MANGOCEUTICALS, INC.      For: Mar 16  Filed by: Cohen Jacob D.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MANGOCEUTICALS%2C+INC.++++++For%3A+Mar+16++Filed+by%3A+Cohen+Jacob+D./26198464.html</link>
   <description>si-local-file:///var/storage/secattach/20260320/26198464.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MANGOCEUTICALS%2C+INC.++++++For%3A+Mar+16++Filed+by%3A+Cohen+Jacob+D./26198464.html</guid>
   <pubDate>Fri, 20 Mar 2026 17:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MGRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54870568</category>
   	  </item>
  <item>
   <title>Form  4          MANGOCEUTICALS, INC.      For: Mar 16  Filed by: Cohen Jacob D.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MANGOCEUTICALS%2C+INC.++++++For%3A+Mar+16++Filed+by%3A+Cohen+Jacob+D./26198464.html</link>
   <description>si-local-file:///var/storage/secattach/20260320/26198464.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MANGOCEUTICALS%2C+INC.++++++For%3A+Mar+16++Filed+by%3A+Cohen+Jacob+D./26198464.html</guid>
   <pubDate>Fri, 20 Mar 2026 17:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MGRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54870568</category>
   	  </item>
  <item>
   <title>Form  4          MANGOCEUTICALS, INC.      For: Jun 05  Filed by: Cohen Jacob D.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MANGOCEUTICALS%2C+INC.++++++For%3A+Jun+05++Filed+by%3A+Cohen+Jacob+D./26198469.html</link>
   <description>si-local-file:///var/storage/secattach/20260320/26198469.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MANGOCEUTICALS%2C+INC.++++++For%3A+Jun+05++Filed+by%3A+Cohen+Jacob+D./26198469.html</guid>
   <pubDate>Fri, 20 Mar 2026 17:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MGRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54870568</category>
   	  </item>
  <item>
   <title>Form  4          MANGOCEUTICALS, INC.      For: Jun 05  Filed by: Cohen Jacob D.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MANGOCEUTICALS%2C+INC.++++++For%3A+Jun+05++Filed+by%3A+Cohen+Jacob+D./26198469.html</link>
   <description>si-local-file:///var/storage/secattach/20260320/26198469.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MANGOCEUTICALS%2C+INC.++++++For%3A+Jun+05++Filed+by%3A+Cohen+Jacob+D./26198469.html</guid>
   <pubDate>Fri, 20 Mar 2026 17:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MGRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54870568</category>
   	  </item>
  <item>
   <title>Mangoceuticals files $73 million lawsuit against former tech vendor</title>
   <link>http://www.streetinsider.com/Litigation/Mangoceuticals+files+%2473+million+lawsuit+against+former+tech+vendor/26174614.html</link>
   <description>&lt;p&gt;Mangoceuticals Inc. (NASDAQ: MGRX) filed a civil lawsuit in Texas state court seeking damages exceeding $73 million against Clarity Ventures Inc., its former technology consulting and software development firm.&lt;/p&gt;&lt;p&gt;The Dallas-based telemedicine company alleges that Clarity failed to deliver a fully functional, HIPAA-compliant enterprise resource planning and eCommerce platform that the firm was contracted to design and implement. The damages sought exclude interest, costs, and attorneys' fees.&lt;/p&gt;&lt;p&gt;Clarity has denied Mangoceuticals' allegations and filed counterclaims related to alleged unpaid invoices. Mangoceuticals stated it believes the counterclaims are unwarranted, asserting that all required payments under applicable agreements were made in full before ending</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Litigation/Mangoceuticals+files+%2473+million+lawsuit+against+former+tech+vendor/26174614.html</guid>
   <pubDate>Tue, 17 Mar 2026 16:00:28 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MGRX</category>
   	  </item>
  <item>
   <title>Mangoceuticals files $73 million lawsuit against former tech vendor</title>
   <link>http://www.streetinsider.com/Corporate+News/Mangoceuticals+files+%2473+million+lawsuit+against+former+tech+vendor/26174614.html</link>
   <description>&lt;p&gt;Mangoceuticals Inc. (NASDAQ: MGRX) filed a civil lawsuit in Texas state court seeking damages exceeding $73 million against Clarity Ventures Inc., its former technology consulting and software development firm.&lt;/p&gt;&lt;p&gt;The Dallas-based telemedicine company alleges that Clarity failed to deliver a fully functional, HIPAA-compliant enterprise resource planning and eCommerce platform that the firm was contracted to design and implement. The damages sought exclude interest, costs, and attorneys' fees.&lt;/p&gt;&lt;p&gt;Clarity has denied Mangoceuticals' allegations and filed counterclaims related to alleged unpaid invoices. Mangoceuticals stated it believes the counterclaims are unwarranted, asserting that all required payments under applicable agreements were made in full before ending</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Mangoceuticals+files+%2473+million+lawsuit+against+former+tech+vendor/26174614.html</guid>
   <pubDate>Tue, 17 Mar 2026 16:00:28 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MGRX</category>
   	  </item>
  <item>
   <title>Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc.</title>
   <link>http://www.streetinsider.com/Press+Releases/Mangoceuticals+Announces+Lawsuit+Seeking+Damages+Exceeding+%2473+Million+Against+Former+Technology+Consulting+and+Software+Development+Firm%2C+Clarity+Ventures%2C+Inc./26174594.html</link>
   <description>&lt;p align=&quot;justify&quot;&gt;Dallas, Texas, March  17, 2026  (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“Mangoceuticals,” the “Company,” or “MangoRx”), a company focused on developing, marketing, and selling health and wellness products through a secure telemedicine platform under the brands MangoRx and PeachesRx, today announced that it has filed a civil lawsuit against Clarity Ventures, Inc., its former technology consulting and software development firm (“Clarity”).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The lawsuit, filed in Texas state court, seeks damages exceeding $73 million, exclusive of interest, costs, and attorneys’ fees. The Company alleges that Clarity failed to deliver a fully functional, HIPAA-compliant enterprise resource</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Mangoceuticals+Announces+Lawsuit+Seeking+Damages+Exceeding+%2473+Million+Against+Former+Technology+Consulting+and+Software+Development+Firm%2C+Clarity+Ventures%2C+Inc./26174594.html</guid>
   <pubDate>Tue, 17 Mar 2026 16:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MGRX</category>
   	  </item>
  <item>
   <title>Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc.</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Mangoceuticals+Announces+Lawsuit+Seeking+Damages+Exceeding+%2473+Million+Against+Former+Technology+Consulting+and+Software+Development+Firm%2C+Clarity+Ventures%2C+Inc./26174594.html</link>
   <description>&lt;p align=&quot;justify&quot;&gt;Dallas, Texas, March  17, 2026  (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“Mangoceuticals,” the “Company,” or “MangoRx”), a company focused on developing, marketing, and selling health and wellness products through a secure telemedicine platform under the brands MangoRx and PeachesRx, today announced that it has filed a civil lawsuit against Clarity Ventures, Inc., its former technology consulting and software development firm (“Clarity”).&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;The lawsuit, filed in Texas state court, seeks damages exceeding $73 million, exclusive of interest, costs, and attorneys’ fees. The Company alleges that Clarity failed to deliver a fully functional, HIPAA-compliant enterprise resource</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Mangoceuticals+Announces+Lawsuit+Seeking+Damages+Exceeding+%2473+Million+Against+Former+Technology+Consulting+and+Software+Development+Firm%2C+Clarity+Ventures%2C+Inc./26174594.html</guid>
   <pubDate>Tue, 17 Mar 2026 16:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MGRX</category>
   	  </item>
  <item>
   <title>Form  8-K        MANGOCEUTICALS, INC.      For: Mar 16</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++MANGOCEUTICALS%2C+INC.++++++For%3A+Mar+16/26174634.html</link>
   <description>si-local-file:///var/storage/secattach/20260317/26174634.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++MANGOCEUTICALS%2C+INC.++++++For%3A+Mar+16/26174634.html</guid>
   <pubDate>Tue, 17 Mar 2026 16:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MGRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54870568</category>
   	  </item>
  <item>
   <title>Form  8-K        MANGOCEUTICALS, INC.      For: Mar 16</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++MANGOCEUTICALS%2C+INC.++++++For%3A+Mar+16/26174634.html</link>
   <description>si-local-file:///var/storage/secattach/20260317/26174634.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++MANGOCEUTICALS%2C+INC.++++++For%3A+Mar+16/26174634.html</guid>
   <pubDate>Tue, 17 Mar 2026 16:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MGRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54870568</category>
   	  </item>
  <item>
   <title>Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds</title>
   <link>http://www.streetinsider.com/Press+Releases/Mangoceuticals%2C+Inc.+Announces+PCT+Patent+Filing+for+MGX-0024+Antiviral+Technology+to+Include+Inhibiting+Respiratory+or+Orally+Acquired+Virus+Infection+in+Animals+or+Birds/26125143.html</link>
   <description>&lt;p align=&quot;justify&quot;&gt;Dallas, TX, March  06, 2026  (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine platform under the brands MangoRx and PeachesRx, and a pioneer in innovative wellness solutions and its partner IntraMont Technologies, Inc. today announced the filing of a Patent Cooperation Treaty (PCT) international application (P-641039-PC) on February 26, 2026, to secure broad global patent protection for the antiviral animal feed and drinking water additive technology that powers MGX-0024.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;This PCT filing directly extends the intellectual property</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Mangoceuticals%2C+Inc.+Announces+PCT+Patent+Filing+for+MGX-0024+Antiviral+Technology+to+Include+Inhibiting+Respiratory+or+Orally+Acquired+Virus+Infection+in+Animals+or+Birds/26125143.html</guid>
   <pubDate>Fri, 06 Mar 2026 16:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MGRX</category>
   	  </item>
  <item>
   <title>Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Mangoceuticals%2C+Inc.+Announces+PCT+Patent+Filing+for+MGX-0024+Antiviral+Technology+to+Include+Inhibiting+Respiratory+or+Orally+Acquired+Virus+Infection+in+Animals+or+Birds/26125143.html</link>
   <description>&lt;p align=&quot;justify&quot;&gt;Dallas, TX, March  06, 2026  (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine platform under the brands MangoRx and PeachesRx, and a pioneer in innovative wellness solutions and its partner IntraMont Technologies, Inc. today announced the filing of a Patent Cooperation Treaty (PCT) international application (P-641039-PC) on February 26, 2026, to secure broad global patent protection for the antiviral animal feed and drinking water additive technology that powers MGX-0024.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;This PCT filing directly extends the intellectual property</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Mangoceuticals%2C+Inc.+Announces+PCT+Patent+Filing+for+MGX-0024+Antiviral+Technology+to+Include+Inhibiting+Respiratory+or+Orally+Acquired+Virus+Infection+in+Animals+or+Birds/26125143.html</guid>
   <pubDate>Fri, 06 Mar 2026 16:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MGRX</category>
   	  </item>
  <item>
   <title>Form  8-K        MANGOCEUTICALS, INC.      For: Feb 23</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++MANGOCEUTICALS%2C+INC.++++++For%3A+Feb+23/26043188.html</link>
   <description>si-local-file:///var/storage/secattach/20260223/26043188.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++MANGOCEUTICALS%2C+INC.++++++For%3A+Feb+23/26043188.html</guid>
   <pubDate>Mon, 23 Feb 2026 16:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">MGRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54870568</category>
   	  </item>
 </channel>
</rss>
